This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.
Dörte Solle
Advertisement
Articles by Dörte Solle
This information is supplementary to the article “Accelerating Monoclonal Antibody Quality Control: The Role of LC–MS in Upstream Bioprocessing”, which was published in the May 2025 issue of Current Trends in Mass Spectrometry.
Advertisement
Latest Updated Articles
- Supplementary Information: Accelerating Monoclonal Antibody Quality Control: The Role of LC–MS in Upstream Bioprocessing
Published: April 3rd 2025 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
